T2D diagnosed within last 6 years may be able to achieve remission if substantial weight loss is achieved.Read More »
Costs vs. Outcomes for Patients With Type 2 Diabetes: The issue of cost in healthcare is a central point in the discussion of the future of medicine. While much is made of the cost of end-of-life care, many of the dollars spent yearly are focused on the treatment of chronic diseases like diabetes. The estimated yearly cost of diabetes care was $245 billion in the U.S. in 2012, the last year for which numbers have been reported. $50 billion of that was related to prescription drug purchases.Read More »
Non-adherence to Metformin Versus Therapeutic Failure: When is it Appropriate to Switch to Second-Line Therapies?
Patients who skipped initial treatment with metformin and were instead started on second-line antihyperglycemic medication more likely to need dual therapy or insulin to control T2.Read More »
Part 1 of a four part series on a framework developed by Dr. Bradley Eilerman and Len Testa for recommending medications for treating patients with type 2 diabetes.
A thousand times today, in offices all over America, hospital patients will be diagnosed with type 2 diabetes. When that happens, a healthcare provider has to make a treatment decision of enormous complexity, often with partial information to go on, and in the span of just a few minutes.
How Does Empagliflozin Reduce Cardiovascular Mortality In Type 2 Patients, Including Those With PAD?
The answer comes from a mediation analysis of the EMPA-REG OUTCOME Trial.Read More »
Understanding The Gap Between Efficacy In Randomized Trials And Effectiveness In Real-World Use Of GLP-1RA and DPP-4 Therapies
Patients are not seeing the expected results because of medication adherence.Read More »
Getting type 2 diabetes at an early age increases risk for all diabetes complications, including death.Read More »
How best to decide whether to use one or a combination of the new treatments and individualize the treatment for your patients.Read More »
With much of the U.S. in the grip of harsh winter weather as December 2017 comes to a close, we're revisiting a post we originally published in 2013 about how having diabetes or prediabetes can increase the risk of frostbite. The risk was dramatically illustrated by the experience of British explorer Sir Ranulph Fiennes, who had to pull out of a grueling expedition to cross Antarctica due to the effects of frostbite. We wish all our readers a healthy, safe, and warm new year!Read More »
Study reports Vitamin D supplementation may improve HbA1c and lower cholesterol.Read More »